397 Harnessing the potential of genetic compensation in amyotrophic lateral sclerosis Authors: Adriana Morales Gomez, Nathan Staff, Stephen C. Ekker Published: 2026 ABSTRACT Objectives/Goals: This study aims to explore transcriptional adaptation, where mutations in one gene trigger compensatory changes in related genes, and how this affects the variability in clinical manifestations of amyotrophic lateral sclerosis (ALS). Methods/Study Population: The presence of a premature termination codon triggers transcriptional activation. Therefore, we utilized CRISPR-Cas9 tool to generate a premature termination codon in CHCHD10 gene in multiple types of cells, including induced pluripotent stem cells derived from patient samples with known CHCHD10 mutations causative for amyotrophic lateral sclerosis. CRISPR-Cas9 tool was delivered via ribonucleoprotein electroporation, and transfect cell’s DNA were sequenced to validate gene editing. To confirm transcriptional adaptation, protein and gene expression changes will be assessed by immunoblotting and quantification of multiple target loci from whole-cell lysates of edited cells. Results/Anticipated Results: By employing CRISPR-Cas9-mediated editing, we hypothesize that transcriptional adaptation will enable the adaptive gene to functionally compensate for the loss of function in the gene of interest harboring a premature termination codon. Discussion/Significance of Impact: The significance of this research lies in its potential to identify novel genes capable of triggering transcriptional adaptation in humans. Understanding this mechanism could pave the way for new therapeutic strategies, particularly for CHCHD10-associated ALS.